Share
Market Research Report

ADULT VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By VaccinesInfluenza · Tetanus · Diphtheria · Pertussis (Td/Tdap) · Varicella · Human Papillomavirus · Zoster · Measles · Mumps · Rubella (MMR) · Pneumococcal · Hepatitis · Others
  • By Vaccine TypeMonovalent and Multivalent
  • By TechnologyLive Attenuated Vaccines · Inactivated Viral/Bacterial Vaccines · Toxoid Vaccines · Recombinant Vaccines · Conjugate Vaccines
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In03 Apr 2026
  • Report CodeCMI1091
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Vaccines
      • Market Snapshot, By Vaccine Type
      • Market Snapshot, By Technology
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Adult Vaccines Market, By Vaccines, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Influenza
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Tetanus, Diphtheria, Pertussis (Td/Tdap)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Varicella
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Human Papillomavirus 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Zoster
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Measles, Mumps, Rubella (MMR)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Pneumococcal
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Hepatitis
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Adult Vaccines Market, By Vaccine Type, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Monovalent
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Multivalent
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Adult Vaccines Market, By Technology, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Live Attenuated Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Inactivated Viral/Bacterial Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Toxoid Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Recombinant Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Conjugate Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  7. Global Adult Vaccines Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction

      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022–2033
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • GlaxoSmithKline plc
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi Pasteur
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AstraZeneca
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novavax, Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Moderna, Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Inovio Pharmaceuticals, Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bavarian Nordic
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Dynavax Technologies Corporation
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • BioNTech S
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Emergent BioSolutions Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bharat Biotech
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sinovac Biotech Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology


    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Adult Vaccines Market” - Global forecast to 2033